title: Identification of a novel LRRK2 mutation linked to autosomal dominant parkinsonism: evidence of a common founder across European populations.
abstract: Autosomal dominant parkinsonism has been attributed to pathogenic amino acid substitutions in leucine-rich repeat kinase 2 (LRRK2). By sequencing multiplex families consistent with a PARK8 assignment, we identified a novel heterozygous LRRK2 mutation. A referral sample of 248 affected probands from families with autosomal dominant parkinsonism was subsequently assessed; 7 (2.8%) were found to carry a heterozygous LRRK2 6055G-->A transition (G2019S). These seven patients originate from the United States, Norway, Ireland, and Poland. In samples of patients with idiopathic Parkinson disease (PD) from the same populations, further screening identified six more patients with LRRK2 G2019S; no mutations were found in matched control individuals. Subsequently, 42 family members of the 13 probands were examined; 22 have an LRRK2 G2019S substitution, 7 with a diagnosis of PD. Of note, all patients share an ancestral haplotype indicative of a common founder, and, within families, LRRK2 G2019S segregates with disease (multipoint LOD score 2.41). Penetrance is age dependent, increasing from 17% at age 50 years to 85% at age 70 years. In summary, our study demonstrates that LRRK2 G2019S accounts for parkinsonism in several families within Europe and North America. Our work highlights the fact that a proportion of clinically typical, late-onset PD cases have a genetic basis.
authors.affiliation: Department of Neuroscience, Mayo Clinic, Jacksonville, FL 32224, USA.
authors.forename: Jennifer
authors.initials: J
authors.lastname: Kachergus
authors.forename: Ignacio F
authors.initials: IF
authors.lastname: Mata
authors.forename: Mary
authors.initials: M
authors.lastname: Hulihan
authors.forename: Julie P
authors.initials: JP
authors.lastname: Taylor
authors.forename: Sarah
authors.initials: S
authors.lastname: Lincoln
authors.forename: Jan
authors.initials: J
authors.lastname: Aasly
authors.forename: J Mark
authors.initials: JM
authors.lastname: Gibson
authors.forename: Owen A
authors.initials: OA
authors.lastname: Ross
authors.forename: Timothy
authors.initials: T
authors.lastname: Lynch
authors.forename: Joseph
authors.initials: J
authors.lastname: Wiley
authors.forename: Haydeh
authors.initials: H
authors.lastname: Payami
authors.forename: John
authors.initials: J
authors.lastname: Nutt
authors.forename: Demetrius M
authors.initials: DM
authors.lastname: Maraganore
authors.forename: Krzysztof
authors.initials: K
authors.lastname: Czyzewski
authors.forename: Maria
authors.initials: M
authors.lastname: Styczynska
authors.forename: Zbigniew K
authors.initials: ZK
authors.lastname: Wszolek
authors.forename: Matthew J
authors.initials: MJ
authors.lastname: Farrer
authors.forename: Mathias
authors.initials: M
authors.lastname: Toft
mesh_terms: D000367:Age Factors; D000368:Aged; D000595:Amino Acid Sequence; D005260:Female; D005787:Gene Frequency; D005799:Genes, Dominant; D006801:Humans; D007494:Ireland; D000071158:Leucine-Rich Repeat Serine-Threonine Protein Kinase-2; D008297:Male; D008875:Middle Aged; D008969:Molecular Sequence Data; D009154:Mutation; D009664:Norway; D010300:Parkinson Disease / Q000235:genetics*; D010375:Pedigree; D019683:Penetrance; D011044:Poland; D017346:Protein Serine-Threonine Kinases / Q000235:genetics*; D014481:United States; D044465:White People / Q000235:genetics
chemical_list: C495280:LRRK2 protein, human; D000071158:Leucine-Rich Repeat Serine-Threonine Protein Kinase-2; D017346:Protein Serine-Threonine Kinases
references.citation: Ann Neurol. 2001 Mar;49(3):313-9
references.pmid: 11261505
references.citation: Ann Neurol. 2002 Mar;51(3):296-301
references.pmid: 11891824
references.citation: Cell. 2002 May 3;109(3):275-82
references.pmid: 12015977
references.citation: J Neurol Neurosurg Psychiatry. 2002 Jun;72(6):686-9
references.pmid: 12023405
references.citation: Hum Hered. 2002;53(2):79-91
references.pmid: 12037407
references.citation: Nature. 2002 Jun 27;417(6892):949-54
references.pmid: 12068308
references.citation: Science. 2003 Jan 10;299(5604):256-9
references.pmid: 12446870
references.citation: Ann Neurol. 2003 Sep;54(3):283-6
references.pmid: 12953260
references.citation: Science. 2003 Oct 31;302(5646):841
references.pmid: 14593171
references.citation: Biochim Biophys Acta. 2003 Dec 7;1643(1-3):5-10
references.pmid: 14654223
references.citation: Am J Hum Genet. 2004 Jan;74(1):11-9
references.pmid: 14691730
references.citation: Ann Neurol. 2004 Feb;55(2):164-73
references.pmid: 14755719
references.citation: Ann Neurol. 2004 Feb;55(2):174-9
references.pmid: 14755720
references.citation: Hum Mol Genet. 2004 Apr 1;13 Spec No 1:R127-33
references.pmid: 14976155
references.citation: Neurology. 2004 May 11;62(9):1619-22
references.pmid: 15136696
references.citation: Science. 2004 May 21;304(5674):1158-60
references.pmid: 15087508
references.citation: Nat Med. 2004 Jul;10 Suppl:S58-62
references.pmid: 15272270
references.citation: Neurology. 2004 Jul 27;63(2):305-11
references.pmid: 15277625
references.citation: Ann Neurol. 2004 Sep;56(3):336-41
references.pmid: 15349860
references.citation: Mol Cell. 2004 Sep 10;15(5):661-75
references.pmid: 15350212
references.citation: Lancet. 2004 Sep 25-Oct 1;364(9440):1167-9
references.pmid: 15451224
references.citation: Ann Neurol. 2004 Oct;56(4):591-5
references.pmid: 15455394
references.citation: J Neurol Neurosurg Psychiatry. 1992 Mar;55(3):181-4
references.pmid: 1564476
references.citation: Nat Genet. 1995 Nov;11(3):241-7
references.pmid: 7581446
references.citation: Neurology. 1995 Dec;45(12):2143-6
references.pmid: 8848182
references.citation: J Neuropathol Exp Neurol. 1996 Mar;55(3):259-72
references.pmid: 8786384
references.citation: Science. 1997 Jun 27;276(5321):2045-7
references.pmid: 9197268
references.citation: Nature. 1997 Aug 28;388(6645):839-40
references.pmid: 9278044
references.citation: Am J Hum Genet. 1997 Nov;61(5):1179-88
references.pmid: 9345087
references.citation: Nat Genet. 1998 Feb;18(2):106-8
references.pmid: 9462735
references.citation: Nature. 1998 Apr 9;392(6676):605-8
references.pmid: 9560156
references.citation: N Engl J Med. 1998 Oct 8;339(15):1044-53
references.pmid: 9761807
references.citation: Arch Neurol. 1999 Jan;56(1):33-9
references.pmid: 9923759
references.citation: JAMA. 1999 Jan 27;281(4):341-6
references.pmid: 9929087
references.citation: Neuron. 2004 Nov 18;44(4):595-600
references.pmid: 15541308
references.citation: Neuron. 2004 Nov 18;44(4):601-7
references.pmid: 15541309